Is Berberine Pcos Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Berberine Pcos Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Importantly, PCOS is strongly associated with significant metabolic disturbances, such as insulin resistance (IR) and dyslipidemia, which elevate the long-term risk for type 2 diabetes and cardiovascular morbidity [,]. [Liu Siqi (2026); evidence level 3] - Metformin improves metabolic parameters as an insulin sensitizer [], but its use is limited by gastrointestinal side effects, variable efficacy, and insufficient evidence as a monotherapy on the core reproductive features like ovulation and hirsutism []. [Liu Siqi (2026); evidence level 3] - Preclinical and clinical studies indicate that natural products such as quercetin, resveratrol, berberine, curcumin, and rutin can exert pleiotropic effects, including enhanced insulin sensitivity, reduced oxidative stress, mitigated chronic inflammation, and modulated hormonal activity. [Liu Siqi (2026); evidence level 3] - 1 2 3 4 5 6 7 Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine–metabolic disorders, affecting approximately 5–18% of reproductive-aged women worldwide []. [Liu Siqi (2026); evidence level 3] - Editorial: A lifecourse perspective on polycystic ovary syndrome (PCOS): bridging gaps in research and practice. [Joshi A (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.